New York State Teachers Retirement System Has $66.96 Million Stake in CME Group Inc. (NASDAQ:CME)

New York State Teachers Retirement System decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 4.6% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 303,469 shares of the financial services provider’s stock after selling 14,612 shares during the period. New York State Teachers Retirement System’s holdings in CME Group were worth $66,960,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Trajan Wealth LLC boosted its stake in CME Group by 11.3% during the 3rd quarter. Trajan Wealth LLC now owns 18,790 shares of the financial services provider’s stock worth $4,146,000 after acquiring an additional 1,905 shares during the last quarter. Fidelis Capital Partners LLC bought a new position in CME Group during the 3rd quarter worth approximately $220,000. Farmers & Merchants Investments Inc. boosted its stake in CME Group by 87.5% during the 3rd quarter. Farmers & Merchants Investments Inc. now owns 1,136 shares of the financial services provider’s stock worth $251,000 after acquiring an additional 530 shares during the last quarter. Integrated Advisors Network LLC boosted its stake in CME Group by 26.6% during the 3rd quarter. Integrated Advisors Network LLC now owns 1,317 shares of the financial services provider’s stock worth $291,000 after acquiring an additional 277 shares during the last quarter. Finally, Pallas Capital Advisors LLC bought a new position in CME Group during the 3rd quarter worth approximately $1,633,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,221 shares of company stock worth $3,351,895. Insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CME. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. Barclays lifted their price target on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Citigroup lifted their price target on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. Finally, Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $222.73.

CME Group Stock Performance

Shares of CME stock opened at $227.26 on Thursday. The company’s fifty day simple moving average is $220.05 and its 200-day simple moving average is $209.23. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a market cap of $81.83 billion, a PE ratio of 25.85, a P/E/G ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.25 earnings per share. Equities research analysts expect that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. CME Group’s payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.